Naltrexone transdermal patch (Nalsyn) has patent granted in USA

Syntropharma are pleased to announce that their novel naltrexone patch has recently been granted a patent in the USA. The product will now commence a Phase I study before entering full development. Nalsyn is being positioned for the treatment of patients suffering with Alcohol and Opiate addiction problems.

Leave a Reply

Your email address will not be published. Required fields are marked *